Microsatellite instability in colorectal cancer K Söreide, EAM Janssen, H Söiland, H Körner, JPA Baak Journal of British Surgery 93 (4), 395-406, 2006 | 389 | 2006 |
The X-linked gene G4. 5 is responsible for different infantile dilated cardiomyopathies P D'Adamo, L Fassone, A Gedeon, EAM Janssen, S Bione, PA Bolhuis, ... The American Journal of Human Genetics 61 (4), 862-867, 1997 | 310 | 1997 |
X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome)(MIM 302060) PG Barth, RJA Wanders, P Vreken, EAM Janssen, J Lam, F Baas Journal of inherited metabolic disease 22 (4), 555-567, 1999 | 253 | 1999 |
Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis K Soreide, EA Janssen, H Körner, JPA Baak The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006 | 214 | 2006 |
De-novo mutation in hereditary motor and sensory neuropathy type I JE Hoogendijk, GW Hensels, EAM Janssen, LJ Valentijn, F Baas, ... The Lancet 339 (8801), 1081-1082, 1992 | 208 | 1992 |
Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder MGW BOL, JANPA BAAK, S Buhr-Wildhagen, AJ Kruse, KH Kjellevold, ... The Journal of urology 169 (4), 1291-1294, 2003 | 192 | 2003 |
Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer E Gudlaugsson, I Skaland, EAM Janssen, R Smaaland, Z Shao, ... Histopathology 61 (6), 1134-1144, 2012 | 159 | 2012 |
Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers JPA Baak, AJ Kruse, SJ Robboy, EAM Janssen, B van Diermen, I Skaland Journal of clinical pathology 59 (10), 1017-1028, 2006 | 158 | 2006 |
Genomics and proteomics in cancer JPA Baak, FRC Path, M Hermsen, G Meijer, J Schmidt, EAM Janssen European journal of cancer 39 (9), 1199-1215, 2003 | 147 | 2003 |
Olaparib monotherapy as primary treatment in unselected triple negative breast cancer HP Eikesdal, S Yndestad, A Elzawahry, A Llop-Guevara, B Gilje, ES Blix, ... Annals of oncology 32 (2), 240-249, 2021 | 145 | 2021 |
Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age I Skaland, EAM Janssen, E Gudlaugsson, J Klos, KH Kjellevold, ... Modern Pathology 20 (12), 1307-1315, 2007 | 132 | 2007 |
Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node–negative breast cancer patients younger than 55 years JPA Baak, PJ van Diest, FJ Voorhorst, E van der Wall, LVAM Beex, ... Journal of clinical oncology 23 (25), 5993-6001, 2005 | 128 | 2005 |
Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers JPA Baak, E Gudlaugsson, I Skaland, LHR Guo, J Klos, TH Lende, ... Breast cancer research and treatment 115, 241-254, 2009 | 105 | 2009 |
Ki67 predicts progression in early CIN: validation of a multivariate progression‐risk model AJ Kruse, J Baak, EA Janssen, KH Kjellevold, B Fiane, K Lovslett, J Bergh, ... Analytical Cellular Pathology 26 (1-2), 13-20, 2004 | 104 | 2004 |
Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression JPA Baak, B Van Diermen, A Steinbakk, E Janssen, I Skaland, GL Mutter, ... Human pathology 36 (5), 555-561, 2005 | 100 | 2005 |
Local immune response in the microenvironment of CIN2–3 with and without spontaneous regression IT Øvestad, E Gudlaugsson, I Skaland, A Malpica, AJ Kruse, ... Modern pathology 23 (9), 1231-1240, 2010 | 93 | 2010 |
Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats T Grimstad, B Bjørndal, D Cacabelos, OG Aasprong, EAM Janssen, ... Scandinavian Journal of Gastroenterology 47 (1), 49-58, 2012 | 87 | 2012 |
Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability AJ Kruse, I Skaland, EA Janssen, S Buhr-Wildhagen, J Klos, MJ Arends, ... International journal of gynecological pathology 23 (2), 100-109, 2004 | 86 | 2004 |
Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2–3 in follow up biopsies and spontaneous regression of CIN2–3 IT Ovestad, U Vennestrøm, L Andersen, E Gudlaugsson, AC Munk, ... Gynecologic oncology 123 (2), 278-283, 2011 | 79 | 2011 |
Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer I Skaland, I Øvestad, EAM Janssen, J Klos, KH Kjellevold, T Helliesen, ... Journal of clinical pathology 61 (1), 68-71, 2008 | 79 | 2008 |